Skip to main content
Equibles

MORGAN STANLEY

Position in GALT — Galectin Therapeutics Inc

CIK 895421 NEW YORK, NY
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$433,721
+$142,435 QoQ
Shares Held
93,475
-10.5% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 98 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 34% Shared 0% None 66%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. GALT ranks #280 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in GALT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $433,721 93,475
2026-03-31 $291,286 104,405
2025-12-31 $1,161,837 279,288
2025-09-30 $968,138 228,335
2025-06-30 $440,191 208,623
2025-03-31 $299,009 245,092
2024-12-31 $374,205 290,084
2024-09-30 $676,718 246,080
2024-06-30 $513,508 227,217
2024-03-31 $441,410 184,691
2023-12-31 $307,342 185,147
2023-09-30 $354,736 184,759
2023-06-30 $266,520 185,084
2023-03-31 $395,489 188,329
2022-12-31 $43,803 38,765
2022-09-30 $61,200 37,547
2022-06-30 $77,099 58,856
2022-03-31 $102,248 63,509
2021-12-31 $193,136 93,303
2021-09-30 $193,875 49,968
2021-06-30 $130,590 40,810
2021-03-31 $57,200 26,360
2020-12-31 $120,202 53,662
2020-09-30 $84,314 31,579
2020-06-30 $199,486 65,192
2020-03-31 $108,801 55,511